Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats

Fertility and Sterility

Volumn 81, Issue SUPPL. 1, 2004, Pages 842-849

  Kitajima, Yoshimitsu ^a   Endo, Toshiaki ^a   Manase, Kengo ^a   Nishikawa, Akira ^a   Shibuya, Masabumi ^b   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Flt 1; Gonadotropin releasing hormone agonist; KDR Flk 1; OHSS; Vascular permeability; VEGF; VEGFR 1; VEGFR 2

Indexed keywords

CHORIONIC GONADOTROPIN; EVANS BLUE; GONADORELIN AGONIST; LEUPRORELIN; MESSENGER RNA; SERIC GONADOTROPIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; FEMALE; HORMONE DETERMINATION; NONHUMAN; NORTHERN BLOTTING; ORGAN WEIGHT; OVARY DISEASE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; COLORING AGENTS; EVANS BLUE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONES; LEUPROLIDE; ORGAN SIZE; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542723111     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.11.012     Document Type: Article

References (31)

1. Navot D., Margalioth E.J., Laufer N., Birkenfeld A., Relou A., Rosler A., et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril. 48:1987;57-61.
2. Rizk B., Meagher S., Fisher A.M. Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod. 5:1990;697-698.
3. Mozes M., Bogokowsky H., Antebi E., Lunenfeld B., Rabau E., Serr D.M., et al. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet. 11:1965;1213-1215.
4. Cluroe A.D., Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 27:1995;344-346.
5. Semba S., Moriya T., Youssef E.M., Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int. 50:2000;549-552.
6. Levy T., Orvieto R., Homburg R., Peleg D., Dekel A., Ben-Rafael Z. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod. 11:1996;1177-1179.
7. Aboulghar M.A., Mansour R.T., Serour G.I., Amin Y.M. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod. 13:1998;2088-2091.
8. Senger D.R., Connolly D.T., Van de Water L., Feder J., Dvorak H.F. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 50:1990;1774-1778.
9. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
10. McClure N., Healy D.L., Rogers P.A., Sullivan J., Beaton L., Haning R.V. Jr, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 344:1994;235-236.
11. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H.A., et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 80:1995;1967-1971.
12. Krasnow J.S., Berga S.L., Guzick D.S., Zeleznik A.J., Yeo K.T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome a preliminary report. Fertil Steril. 65:1996;552-555.
13. Ujioka T., Matsuura K., Kawano T., Okamura H. Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod. 12:1997;1629-1634.
14. Goto T., Endo T., Henmi H., Kitajima Y., Kiya T., Nishikawa A., et al. Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats. J Endocrinol. 161:1999;393-402.
15. Kitajima Y., Endo T., Henmi H., Goto T., Kiya T., Nishikawa A., et al. Gonadotropin-releasing hormone agonist suppresses the expression of vascular endothelial growth factor and its receptors mRNA in newly formed corpora lutea. [abstract no. 114] Biol Reprod. 58:(suppl 1):1998;107.
16. Gomez R., Simon C., Remohi J., Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 143:2002;4339-4348.
17. Endo T., Honnma H., Hayashi T., Chida M., Yamazaki K., Kitajima Y., et al. Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos. Hum Reprod. 17:2002;2548-2551.
18. Utsumi H., Chiba H., Kamimura Y., Osanai M., Igarashi Y., Tobioka H., et al. Expression of GFRalpha-1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am J Physiol Cell Physiol. 279:2000;C361-368.
19. Sawano A., Takahashi T., Yamaguchi S., Aonuma M., Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 7:1996;213-221.
20. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene. 9:1994;2683-2690.
21. Takahashi T., et al. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene. 14:1997;2079-2089.
22. Shibuya M. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res. 67:1995;281-316.
23. Ravindranath N., Little-Ihrig L., Phillips H.S., Ferrara N., Zeleznik A.J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology. 131:1992;254-260.
24. Phillips H.S., Hains J., Leung D.W., Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology. 127:1990;965-967.
25. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest. 91:1993;2235-2243.
26. Sudo K., Masaki T., Shiota K., Kawase M., Fujita T. Endocrinological studies on TAP-144-SR, a sustained-release formulation of a potent GnRH agonist (D-Leu6-. [des-Gly10-NH2]-GnRH ethylamide), in male rats Endocrinol Jpn. 37:1990;685-693.
27. Kaiser U.B. Zhao D, Cardona GR, Chin WW. Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun. 189:1992;1645-1652.
28. Whitelaw P.F., Eidne K.A., Sellar R., Smyth C.D., Hillier S.G. Gonadotropin-releasing hormone receptor messenger ribonucleic acid expression in rat ovary. Endocrinology. 136:1995;172-179.
29. Kogo H., Fujimoto T., Park M.K., Mori T. Gonadotropin-releasing hormone receptor mRNA expression in the ovaries of neonatal and adult rats. Cells Tissues Organs. 164:1999;14-22.
30. Harwood J.P., Clayton R.N., Catt K.J. Ovarian gonadotropin-releasing hormone receptors. I. Properties and inhibition of luteal cell function. Endocrinology. 107:1980;407-413.
31. Harwood J.P., Clayton R.N., Chen T.T., Knox G., Catt K.J. Ovarian gonadotropin-releasing hormone receptors. II. Regulation and effects on ovarian development. Endocrinology. 107:1980;414-421.